SPONSORED CONTENT Stay ahead of the latest developments shaping the 340B landscape with Ted Slafsky, Publisher and CEO of 340B […]
SPONSORED CONTENT Introduction: Navigating Political Headwinds As the 2025 political season heats up, federally qualified health centers (FQHCs), hospitals, STD […]
SPONSORED CONTENT The term “specialty medication” is often associated with a hefty price tag and numerous challenges related to claims […]
SPONSORED CONTENT As we endure Spring 2025, many covered entities (CEs) continue to perform their ordinary and necessary duties to […]
SPONSORED CONTENT Please join on us April 22nd at 1:00 p.m. EST for the third installment of RxParadigm’s 340B Clearinghouse […]
SPONSORED CONTENT At the 340B Coalition winter conference in February, two major topics were impossible to ignore: the growing interest […]
SPONSORED CONTENT W. Edwards Deming is a renowned statistician and expert in quality management. He is often quoted as saying, […]
SPONSORED CONTENT The 340B program has come under increased scrutiny within the past five years. Opponents often claim it is […]
SPONSORED CONTENT A HRSA audit is not a question of if but when. Therefore, it is crucial for covered entities […]
SPONSORED CONTENT Let me start by saying that I have been to the 340B Coalition conferences since 2012, and every […]